Guro Aune - Gynecology

Author Information

Guro Aune is associated with the Department of Gynecologic Oncology, Dept. of Obstetrics and Gynecology, St Olav's Hospital, Trondheim University Hospital, and the Department of Clinical and Molecular Medicine at the Norwegian University of Science and Technology in Trondheim, Norway. She has made significant contributions to gynecologic oncology, particularly in the areas of endometrial and ovarian cancer.

Research Contributions

Guro Aune has been actively involved in research focusing on gynecologic cancers, specifically endometrial and ovarian cancer. Her work includes studies on the long-term outcomes of robot-assisted laparoscopic surgery with sentinel lymph node mapping in endometrial cancer patients, the use of positron emission tomography/computed tomography in preoperative risk assessment, and the prevalence of human papillomavirus infection among women in rural Nepal. She has also contributed to understanding the molecular markers and circulating factors associated with ovarian carcinoma, which can help in identifying aggressive forms of the disease and markers of poor prognosis.

Aliases

G. Aune, Guro Aune

Publication and Citation Metrics

Metric	Value
Citation Count	223
h-index	6
Paper Count	15

Publications:

"Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping".

DOI: 10.1016/j.ejogrb.2022.02.003

Year: 2022

410 Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping

DOI: 10.1136/ijgc-2021-esgo.140

Year: 2021

Real-life data of niraparib maintenance treatment in patients with recurrent platinum-sensitive ovarian cancer.

DOI: 10.1200/JCO.2021.39.15_SUPPL.5560

Year: 2021

Initial experience with positron emission tomography/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients.

DOI: 10.1016/j.ejogrb.2021.01.052

Year: 2021

Prevalence of human papillomavirus infection among women in rural Nepal

DOI: 10.1111/aogs.13036

Year: 2017

Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.

DOI: 10.1016/j.ygyno.2016.10.029

Year: 2016

Circulating interleukin-8 and plasminogen activator inhibitor-1 are increased in women with ovarian carcinoma.

DOI: 10.1016/j.rinim.2012.10.003

Year: 2012

Clinical, Pathological, and Molecular Classification of Ovarian Carcinoma

DOI:

Year: 2011

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.

DOI:

Year: 2011

Increased circulating hepatocyte growth factor (HGF): a marker of epithelial ovarian cancer and an indicator of poor prognosis.

DOI: 10.1016/j.ygyno.2010.12.355

Year: 2011

How is Individualized Treatment Planned?

How Important Is Regular Screening and Preventive Care?

How Does Metabolic Rate Affect Women's Health?

What are the Key Applications?

How Can Lifestyle Impact Gynecological Health?

Why Are Teen Pregnancies a Concern?

What are Over-the-Counter Pain Relievers?

What is the ethical approach to end-of-life care in gynecology?

Are There Specific Guidelines for Pregnant Women?

What is Shared Decision-Making?

Partnered Content Networks

Relevant Topics